about
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tra...
Read More
0.80
-0.02
(-2.44%)
80,693
XNAS Volume
XNAS 11 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
RenovoRx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..